Bonnet, F., & Scheen, A. (2017). Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes. Diabetes and Metabolism. doi:10.1016/j.diabet.2017.04.004 https://hdl.handle.net/2268/216136
The most cited
302 citations (OpenAlex)
Bonnet, F., & Scheen, A. (2018). Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease. Diabetes and Metabolism. doi:10.1016/j.diabet.2018.09.005 https://hdl.handle.net/2268/230403
